Dubai: – Digital medical technology company Brainlab announced today that it will present its Mixed Reality Viewer* at the upcoming Arab Health to be held in Dubai from 27 to 30 January 2020. The new technology brings spatial computing into daily clinical practice for surgical plan review, medical student training and patient consultation.

Brainlab Mixed Reality (MR) Viewer uses the head-mounted display Magic Leap One from Brainlab strategic development partner Magic Leap to add a new dimension to patient scans by freeing them from the screen. Up to four users can interact with these photorealistic images in the room, walking around them to gain new perspectives on the patient’s specific anatomy. Brainlab Mixed Reality Viewer is CE labelled and is now available in Europe, with FDA clearance expected to follow later this year.

“Mixed reality offers surgeons a completely new perspective on medical data,” commented Stefan Vilsmeier, President and Chief Executive Officer, Brainlab. “First we had the mouse before touchscreens revolutionized interaction with patient images. Now with mixed reality, users can walk around and dive inside these images created with the latest rendering technology used in gaming applications. This radical perspective change is just the first step in the next medical image visualization revolution.”

Brainlab Mixed Reality Viewer is based on the company’s Elements 3D Viewer software which is already in use in thousands of hospitals around the world. The system provides high-fidelity, gaming-quality graphics that allow medical professionals to experience data as never before. With these case-specific hyper-realistic 3D visualizations, medical students can gain valuable knowledge and patients a better understanding of their specific anatomy and the planned surgical approach.

Image data becomes virtual, patient-specific 3D model

Users can place and interact with patient-specific 3D models in the room by resizing, scrolling through scan layers, and more. Collaboration mode allows multiple specialists to simultaneously view and move around that model, even remotely from anywhere in the hospital network. A virtual pointer facilitates discussion by allowing users to visually indicate anatomical areas critical to the case. Thanks to easy set-up, clinicians can start using the system immediately upon receipt.

James McArthur, General Manager of GenesisCare UK, the first healthcare provider in the UK to use Brainlab Mixed Reality Viewer, commented: “At GenesisCare, we pride ourselves on doing whatever it takes to improve cancer treatment for our patients. Brainlab Mixed Reality Viewer enables our clinicians to show their patients information in a new, more accessible way. Mixed reality will help our clinicians to make tailored treatment decisions and allow our patients to understand their cancer treatment in a way that was not possible before.”

Thanks to an exclusive partnership with Magic Leap, Brainlab is bringing significant advancements in spatial computing to a broad range of medical procedures in the fields of general surgery, spine, trauma, vascular, craniomaxillofacial (CMF) and neurosurgery as well as radiotherapy and radiosurgery. In the future, more indications and applications are planned, including bringing MR into the operating room to be used during surgery.

The open framework operating system, which forms the basis for Brainlab Mixed Reality, allows third parties to develop medical applications to further advance the field of spatial computing.

During Arab Health 2020, Brainlab will also present Loop-X™, the first mobile intraoperative imaging robot which sits at the core of the Brainlab Digital Surgery portfolio for the rapidly evolving spinal market.

To learn more about Mixed Reality from Brainlab, visit:  


About Brainlab

Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, ENT, CMF, spine and trauma.

Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 12,850 systems installed in over 100 countries. Brainlab employs almost 1,400 people in 18 offices worldwide, including more than 420 Research & Development engineers, who form a crucial part of the product development team.

For more information: 

Media Contact:
Fadwa Omar
bridge:media FZ-LLC
Dubai, UAE
Phone: +971 4 3754336
Mobile : 0551332581

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.